CTRI/2023/04/051473尚未招募2 期
Study the effect of nisha amalaki (as an adjuvant drug ) in uncontrolled type II diabetes mellitus a pragmatic randomised controlled trial.
datta meghe institute of higher studies and research0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •patients of T1DM of 30 to 70 years of age having HbA1C between 7 to 10%
排除标准
- •known case of CHF, CKD,cirrohsis of liver
- •pregnancy and lactation
- •severely ill patients
研究者
相似试验
尚未招募
不适用
To Study the effect of Nisha-amalaki as an adjuvant drug in uncontrolled Type II Diabetes mellitusCTRI/2020/12/029806Mahatma Gandhi Ayurved College Hospital and Research Center
进行中（未招募）
3 期
Management of Jataja Prameha (JUvenile Diabetes) with Modified Nisha Amalaki YogaCTRI/2018/03/012270IPGT and RA
已完成
2 期
Effect of an Ayurvedic Drug compound as an Adjuvant therapy on Tuberculosis in Children.CTRI/2011/11/002175Director100
尚未招募
2 期
To check The Effect of Ghrit Madhu Anjana In diabetic Retinopathy patientCTRI/2022/06/043067Dean Parul Institute of Ayurveda
招募中
3 期
Research study on the effect of Amalaki (Indian gooseberry fruit powder) in age related changes among healthy volunteers of 50-59 years age group.CTRI/2019/04/018396Government Ayurved College